Union Square Park Capital Management LLC lifted its stake in shares of Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 233.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,000,000 shares of the health services provider’s stock after purchasing an additional 700,000 shares during the quarter. Teladoc Health comprises approximately 3.4% of Union Square Park Capital Management LLC’s portfolio, making the stock its 8th biggest position. Union Square Park Capital Management LLC’s holdings in Teladoc Health were worth $7,000,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the stock. ExodusPoint Capital Management LP raised its stake in shares of Teladoc Health by 108.0% during the fourth quarter. ExodusPoint Capital Management LP now owns 92,540 shares of the health services provider’s stock worth $648,000 after purchasing an additional 48,060 shares during the last quarter. Bank Hapoalim BM raised its stake in shares of Teladoc Health by 18.9% during the fourth quarter. Bank Hapoalim BM now owns 157,841 shares of the health services provider’s stock worth $1,105,000 after purchasing an additional 25,100 shares during the last quarter. Graham Capital Management L.P. purchased a new stake in shares of Teladoc Health during the fourth quarter worth approximately $359,000. Verition Fund Management LLC raised its stake in shares of Teladoc Health by 57.3% during the fourth quarter. Verition Fund Management LLC now owns 343,916 shares of the health services provider’s stock worth $2,407,000 after purchasing an additional 125,344 shares during the last quarter. Finally, Bridgewater Associates LP raised its stake in shares of Teladoc Health by 31.2% during the fourth quarter. Bridgewater Associates LP now owns 634,479 shares of the health services provider’s stock worth $4,441,000 after purchasing an additional 150,730 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Teladoc Health Trading Up 1.5%
Shares of TDOC opened at $7.58 on Wednesday. Teladoc Health, Inc. has a twelve month low of $4.40 and a twelve month high of $9.77. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The firm has a market capitalization of $1.37 billion, a P/E ratio of -7.81 and a beta of 2.14. The firm’s 50-day moving average is $6.47 and its two-hundred day moving average is $6.22.
Analyst Upgrades and Downgrades
Several equities research analysts have recently commented on the company. Wells Fargo & Company cut their price target on Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a research note on Thursday, February 26th. Canaccord Genuity Group cut their price target on Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Leerink Partners cut their price target on Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a research note on Thursday, February 26th. Stifel Nicolaus cut their price target on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a research note on Thursday, February 26th. Finally, Weiss Ratings upgraded Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday, May 22nd. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $7.43.
Get Our Latest Report on Teladoc Health
Insider Transactions at Teladoc Health
In other news, insider Adam C. Vandervoort sold 7,906 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $60,322.78. Following the sale, the insider owned 110,261 shares of the company’s stock, valued at $841,291.43. The trade was a 6.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the business’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $47,275.48. Following the sale, the insider directly owned 57,671 shares in the company, valued at $440,029.73. This trade represents a 9.70% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 39,870 shares of company stock worth $302,507 over the last quarter. Insiders own 0.70% of the company’s stock.
Teladoc Health Profile
Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.
Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.
Featured Stories
- Five stocks we like better than Teladoc Health
- Could a Tesla-SpaceX Merger Be Closer Than Investors Think?
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
